JPMorgan Chase & Co. Boosts Clorox (NYSE:CLX) Price Target to $174.00

Clorox (NYSE:CLX) had its target price upped by JPMorgan Chase & Co. from $148.00 to $174.00 in a report issued on Friday morning, Benzinga reports. They currently have a neutral rating on the stock.

Other equities research analysts also recently issued research reports about the stock. Citigroup boosted their target price on shares of Clorox from $165.00 to $170.00 and gave the company a neutral rating in a research note on Friday, September 6th. Jefferies Financial Group upgraded shares of Clorox from a hold rating to a buy rating and boosted their target price for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. TD Cowen started coverage on Clorox in a report on Tuesday, July 23rd. They issued a sell rating and a $122.00 price target for the company. Deutsche Bank Aktiengesellschaft lifted their price target on Clorox from $144.00 to $151.00 and gave the company a hold rating in a report on Friday, August 2nd. Finally, Wells Fargo & Company cut their price target on Clorox from $135.00 to $130.00 and set an underweight rating for the company in a report on Wednesday, July 10th. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of Hold and an average price target of $150.14.

Clorox Stock Up 0.8 %

CLX opened at $161.59 on Friday. Clorox has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The firm’s fifty day moving average price is $157.74 and its two-hundred day moving average price is $144.78. The company has a market capitalization of $20.07 billion, a P/E ratio of 83.73, a P/E/G ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. On average, analysts anticipate that Clorox will post 6.64 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.02%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is 252.85%.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.51% of the stock is owned by company insiders.

Hedge Funds Weigh In On Clorox

Several institutional investors and hedge funds have recently made changes to their positions in CLX. GoalVest Advisory LLC bought a new stake in Clorox in the 1st quarter valued at $31,000. First Foundation Advisors bought a new stake in Clorox in the 1st quarter valued at $31,000. Innealta Capital LLC bought a new stake in Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC lifted its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares in the last quarter. Finally, Quarry LP lifted its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.